EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A novel platelet-rich plasma clinically induces reliable, rapid, long-term chronic peripheral neuropathic pain elimination

Damien P Kuffler, Onix Reyes, Ivan J Sosa, Christian A Foy

Experimental Biology and Medicine · 2026

DOI: 10.3389/ebm.2026.10907 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental Biology and Medicine, 2026. Verfasst von Damien P Kuffler und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Neurobiology, Medical School, University of Puerto Rico, San Juan, PR, United States. Hauptthemen laut MEDLINE: Platelet-Rich Plasma, Neuralgia, Peripheral Nerve Injuries. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Peripheral nerve trauma results in 50%–84% of patients developing chronic neuropathic pain, which is eliminated when axons reinnervate targets. Autografts reduce pain by promoting target reinnervation. We hypothesized that applying a novel platelet-rich plasma (PRP) formulation to proximal stumps would permanently eliminate the pain. This prospective case series compared analgesia levels after bridging nerve gaps with an autograft (autograft repair) vs. a PRP-filled collagen tube (PRP repair). Autograft repairs were performed on 16 nerves with a 5.75-cm mean gap length, 2.0-year repair delay, 42.3-year age, and 8.6 chronic neuropathic pain. PRP repairs were performed on 10 nerves with a 6.0-cm gap length, 1-year repair delay, 36.7-year age, with 88% having 9.1 chronic neuropathic pain. For autograft repairs, the pain began to decrease when axons reinnervated targets, reaching a mean of 0.3 in 18.2% of patients, and was eliminated in 81.8%. Following PRP repairs, the pain reduction began within 2 weeks and was eliminated by 2 months. Thus, autografts contribute to pain reduction/elimination by promoting target reinnervation. However, PRP directly and rapidly induced long-term pain elimination in all patients, while axons were regenerating, and without target reinnervation. These results prove that platelet-released factors reliably and rapidly eliminate chronic neuropathic pain.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Platelet-Rich PlasmaNeuralgiaPeripheral Nerve InjuriesHumansFemaleMaleAdultProspective StudiesMiddle AgedNerve Regeneration

Stichwörter der Autor:innen

PRPautograftschronic neuropathic painnerve regenerationnerve trauma

Autor:innen und Institutionen

  • Institute of Neurobiology, Medical School, University of Puerto Rico, San Juan, PR, United States.
  • Doctor's Center Hospital, Manati, PR, United States.
  • Section of Neurosurgery, Medical School, University of Puerto Rico, San Juan, PR, United States.
  • Section of Orthopedic Surgery, Medical Sciences Campus, University of Puerto Rico, San Juan, PR, United States.

Zitieren

APA

Kuffler, D. P., Reyes, O., Sosa, I. J., & Foy, C. A. (2026). A novel platelet-rich plasma clinically induces reliable, rapid, long-term chronic peripheral neuropathic pain elimination. Experimental Biology and Medicine. https://doi.org/10.3389/ebm.2026.10907

Vancouver

Kuffler DP, Reyes O, Sosa IJ, Foy CA. A novel platelet-rich plasma clinically induces reliable, rapid, long-term chronic peripheral neuropathic pain elimination. Experimental Biology and Medicine. 2026. doi:10.3389/ebm.2026.10907

BibTeX
@article{Kuffler2026,
  author = {Kuffler, Damien P and Reyes, Onix and Sosa, Ivan J and Foy, Christian A},
  title = {A novel platelet-rich plasma clinically induces reliable, rapid, long-term chronic peripheral neuropathic pain elimination},
  journal = {Experimental Biology and Medicine},
  year = {2026},
  doi = {10.3389/ebm.2026.10907}
}
Kostenlos starten →